Association between Osteopontin and Hormone Receptor Status among Breast Cancer Patients

Authors

  • Raga Salah Eldeen Khogaly, Abdelkarim Abobaker Abdrabo, Waleed Abdelateif Hussein, Rimaz Elhag Gurashi, Amar Mohamed Ismail

DOI:

https://doi.org/10.53350/pjmhs20221612447

Abstract

Background: Breast cancer (BC) is problem in developed and developing nations and is linked to a high mortality rate.

Objective: In this study, we determined the relationships between osteopontin level, hormonal status, stage, BMI, and age in BC patients.

Materials and Methods: In a cross‑sectional 178 BC patients, ages ranged from 28 to 95 were randomly enrolled. Body mass index were estimated. Plasma osteopontin were measured.

Results: From total of 178 BC patients, 54 (30.3 %) were trilpe negative, 124 (69.7%.) were hormone receptor positive. 86 (48.3%) had high plasma OPN level and 92 (51.7%) with OPN ≤ 55. Chi‑square analyses show that osteopontin was significantly associated with triple negative breast cancer and tumor stage with (P = 0.002 and 0.011), and (odd ratio 1.653,1.604) respectively.

Conclusion: High OPN associated with hormone receptor and tumor stage in breast cancer patients.

Keywords: Osteopontin, BC, Hormone, Receptors

Downloads

How to Cite

Raga Salah Eldeen Khogaly, Abdelkarim Abobaker Abdrabo, Waleed Abdelateif Hussein, Rimaz Elhag Gurashi, Amar Mohamed Ismail. (2023). Association between Osteopontin and Hormone Receptor Status among Breast Cancer Patients. Pakistan Journal of Medical & Health Sciences, 16(12), 447. https://doi.org/10.53350/pjmhs20221612447